Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
FMCG - An investment opportunity - Views on News from Equitymaster
  • E-MAIL
  • A  A  A
  • May 11, 2000

    FMCG - An investment opportunity

    Domestic subsidiaries of multinational parents (MNCs) continue to outperform in the current year in terms of financial performance. Despite this, in recent months, domestic FMCG stocks have not found many takers.

    Unmatched performance
    MNC companies the world over are facing stiff competition across all product categories. This has resulted in slowdown in their topline growth. Their Indian counterpartson the other hand seem to chugging along smoothly. As can be seen from the table while Unilever witnessed negative growth rate both in turnover and profits, HLL its Indian subsidiary registered robust growth in financial performance.

    Also the profit margins of domestic subsidiaries are comparatively better. The operating profit margin of the US based giant P&G is nowhere comparable to that enjoyed by Procter & Gamble Hygiene & Healthcare (PGHH) in India. The reason for higher margins enjoyed by Indian companies are their stringent cost control measures, low raw material cost and cheap availability of man power. We have compared growth ratios and profit margins for the comparison in the following table.

    Key ratios of select international companies
    Particulars Unilever P&G Cadbury
    Nestle SA Colgate Gillette
    Sales ($ bn) 43.7 38.1 6.8 4.6 9.1 9.9
    Growth 2.8% 3.0% 5.9% 4.1% 1.6% -2.0%
    Net profit ($ bn) 3.2 3.8 0.8 2.9 0.9 1.3
    Growth -7.7% 4.4% 5.4% 12.3% 10.5% -12.0%
    Op. profit margins 10.5% 13.8% 16.2% 9.9% 17.9% 21.2%
    Net profit margins 7.3% 9.9% 11.1% 6.3% 10.3% 12.7%

    Key ratios of select domestic subsidiary companies
    Particulars HLL PGHH Cadbury Nestle Colgate ISPL
    Sales (Rs bn) 101.4 4.7 5.1 15.4 11.0 2.5
    Growth 7.0% 6.3% 19.3% -3.5% 10.0% 28.3%
    Net profit (Rs bn) 10.7 0.6 0.4 1.1 0.6 0.2
    Growth 27.7% 29.4% 52.7% 24.1% 25.0% 5.7%
    Op. profit margins 12.0% 18.3% 15.2% 15.2% 9.0% 17.8%
    Net profit margins 10.5% 11.8% 7.5% 6.9% 5.0% 7.7%

    All in all, the conclusion is instead of investing in International markets where the growth rate of the MNCs are skewed and profit margins are narrowing, the higher growth in the Indian market provides good opportunity to invest. FMCG companies worldwide are getting lower valuations due to slower topline growth. Then there is the new focus on technology stocks. However long term prospects for the sector in India appear to be bright. Also the setbacks to the universe of FMCG stocks in the past few months offers good capital appreciation opportunity from the current level.



    Equitymaster requests your view! Post a comment on "FMCG - An investment opportunity". Click here!


    More Views on News

    Marico: Earnings Hit by Lower Volumes and Firming Input Prices (Quarterly Results Update - Detailed)

    Aug 9, 2017

    While GST implementation brought down volumes and profitability in the short run, Marico remains optimistic in the long run.

    P&G: Strong Core Growth (Quarterly Results Update - Detailed)

    Dec 9, 2016

    Procter & Gamble Hygiene and Health Care has announced the first quarter results of the financial year ended June 2017 (1QFY17). The company's sales rose by 12.5%YoY while net profit rose by 50.1% YoY during the quarter.

    Nestle India: Sales Traction From New Products (Quarterly Results Update - Detailed)

    Nov 30, 2016

    Nestle India declared results for the quarter ended September 2016. Here is our analysis of the result.

    GSK Consumer: Price Hike Hurts Volumes (Quarterly Results Update - Detailed)

    Nov 30, 2016

    GSK Consumer Healthcare declared results for the quarter ended September 2016. The revenues dropped by 1.3% during the quarter as compared to a year ago; while the profits declined by 16.6% YoY during the quarter.

    Marico: Margin Expansion Drives Profit Growth (Quarterly Results Update - Detailed)

    Nov 28, 2016

    Marico has reported a flat topline while the bottomline has grown by 18% YoY during the quarter.

    More Views on News

    Most Popular

    This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

    Aug 17, 2017

    A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

    Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

    Aug 21, 2017

    Most Indians who cannot find jobs, look at becoming self-employed.

    It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

    Aug 16, 2017

    The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

    5 Steps To Become Financially Independent(Outside View)

    Aug 16, 2017

    Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

    Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

    Aug 22, 2017

    Post demonetisation, a cut in bank savings deposits rates was in the offing.

    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms


    Aug 23, 2017 (Close)